In vivo evidences suggesting the role of oxidative stress in pathogenesis of <info type="ChemicalEntity">vancomycin</info>-induced <info type="DiseaseOrPhenotypicFeature">nephrotoxicity</info>: protection by <info type="ChemicalEntity">erdosteine</info>. 

The aims of this study were to examine <info type="ChemicalEntity">vancomycin</info> (<info type="ChemicalEntity">VCM</info>)-induced oxidative stress that promotes production of <info type="ChemicalEntity">reactive oxygen species</info> (<info type="ChemicalEntity">ROS</info>) and to investigate the role of <info type="ChemicalEntity">erdosteine</info>, an expectorant agent, which has also antioxidant properties, on kidney tissue against the possible <info type="ChemicalEntity">VCM</info>-induced renal impairment in <info type="OrganismTaxon">rats</info>. <info type="OrganismTaxon">Rats</info> were divided into three groups: sham, <info type="ChemicalEntity">VCM</info> and <info type="ChemicalEntity">VCM</info> plus <info type="ChemicalEntity">erdosteine</info>. <info type="ChemicalEntity">VCM</info> was administrated intraperitoneally (i.p.) with <info type="ChemicalEntity">200mgkg(-1)</info> twice daily for <info type="ChemicalEntity">7 days</info>. <info type="ChemicalEntity">Erdosteine</info> was administered orally. <info type="ChemicalEntity">VCM</info> administration to control <info type="OrganismTaxon">rats</info> significantly increased renal <info type="ChemicalEntity">malondialdehyde</info> (<info type="ChemicalEntity">MDA</info>) and urinary <info type="ChemicalEntity">N-acetyl-beta-d-glucosaminidase</info> (<info type="ChemicalEntity">NAG</info>, a marker of renal tubular injury) excretion but decreased <info type="ChemicalEntity">superoxide dismutase</info> (<info type="ChemicalEntity">SOD</info>) and <info type="ChemicalEntity">catalase</info> (<info type="ChemicalEntity">CAT</info>) activities. <info type="ChemicalEntity">Erdosteine</info> administration with <info type="ChemicalEntity">VCM</info> injections caused significantly decreased renal <info type="ChemicalEntity">MDA</info> and urinary <info type="ChemicalEntity">NAG</info> excretion, and increased <info type="ChemicalEntity">SOD</info> activity, but not <info type="ChemicalEntity">CAT</info> activity in renal tissue when compared with <info type="ChemicalEntity">VCM</info> alone. <info type="ChemicalEntity">Erdosteine</info> showed histopathological protection against <info type="ChemicalEntity">VCM</info>-induced <info type="DiseaseOrPhenotypicFeature">nephrotoxicity</info>. There were a significant dilatation of <info type="DiseaseOrPhenotypicFeature">tubular lumens</info>, extensive <info type="DiseaseOrPhenotypicFeature">epithelial cell vacuolization</info>, <info type="DiseaseOrPhenotypicFeature">atrophy</info>, <info type="DiseaseOrPhenotypicFeature">desquamation</info>, and <info type="DiseaseOrPhenotypicFeature">necrosis</info> in <info type="ChemicalEntity">VCM</info>-treated <info type="OrganismTaxon">rats</info> more than those of the control and the <info type="ChemicalEntity">erdosteine</info> groups. <info type="ChemicalEntity">Erdosteine</info> caused a marked reduction in the extent of tubular damage. It is concluded that oxidative tubular damage plays an important role in the <info type="ChemicalEntity">VCM</info>-induced <info type="DiseaseOrPhenotypicFeature">nephrotoxicity</info> and the modulation of oxidative stress with <info type="ChemicalEntity">erdosteine</info> reduces the <info type="ChemicalEntity">VCM</info>-induced kidney damage both at the biochemical and histological levels.